These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2308574)

  • 1. Risks of viral transmission by blood products: current status of preventive measures.
    Chaplin H; Ramos R
    Mo Med; 1990 Jan; 87(1):37-40. PubMed ID: 2308574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal liability for transfusion injury in the acquired immunodeficiency syndrome era.
    Zuck TF
    Arch Pathol Lab Med; 1990 Mar; 114(3):309-15. PubMed ID: 2407220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted AIDS reassessed.
    Zuck TF
    N Engl J Med; 1988 Feb; 318(8):511-2. PubMed ID: 3340131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS risk and prevention in transfusions.
    Hamerschlak N
    Nat Immun Cell Growth Regul; 1990; 9(3):150-4. PubMed ID: 2370875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current risks in blood transfusion in Japan.
    Otsubo H; Yamaguchi K
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for transfusion-transmitted viral infections in the United States.
    Chamberland ME
    Biologicals; 1998 Jun; 26(2):85-8. PubMed ID: 9811510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing risk of viral transfusion-transmitted diseases in Croatia.
    Grgicević D; Balija M; Pirc-Tiljak D; Mihaljević I; Gjenero-Margan I; Zupancić-Salek S; Macek P
    Croat Med J; 2000 Jun; 41(2):191-6. PubMed ID: 10853051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after ten years.
    Busch MR
    Dev Biol (Basel); 2007; 127():87-112. PubMed ID: 17486883
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfusion-transmitted infectious diseases.
    Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
    Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protection of hospital personnel against risks of exposure to blood].
    Bouvet E; Tarantola A
    Rev Prat; 1998 Sep; 48(14):1558-62. PubMed ID: 9814052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS and hemophilia--current issues.
    Evatt BL
    Thromb Haemost; 1995 Jul; 74(1):36-9. PubMed ID: 8578484
    [No Abstract]   [Full Text] [Related]  

  • 12. Southern Calif. providers launch campaign to test transfusion recipients for AIDS virus.
    Taravella S
    Mod Healthc; 1990 May; 20(21):36. PubMed ID: 10104894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006.
    Polizzotto MN; Wood EM; Ingham H; Keller AJ;
    Transfusion; 2008 Jan; 48(1):55-63. PubMed ID: 17894794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious risks of blood transfusion.
    Uhl L
    Curr Hematol Rep; 2002 Nov; 1(2):156-62. PubMed ID: 12901138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal].
    Kretschmer V
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HIV infection on the hemophilia community.
    Whitney CK
    Ment Retard; 1989 Aug; 27(4):227-8. PubMed ID: 2586311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warning on blood transfusions and AIDS evoked less public fear than expected.
    McLaughlin N
    Mod Healthc; 1987 May; 17(10):86. PubMed ID: 10314219
    [No Abstract]   [Full Text] [Related]  

  • 19. Ways to reduce the risk of transmission of viral infections by plasma and plasma products. A comparison of methods, their advantages and disadvantages.
    Vox Sang; 1988; 54(4):228-45. PubMed ID: 3388821
    [No Abstract]   [Full Text] [Related]  

  • 20. Informed consent, risk, and blood transfusion.
    Kolins J; Kolins MD
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):88-91. PubMed ID: 2366570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.